Full-Time

Sr Quality Engineer

Electronics

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Compensation Overview

$125k - $175k/yr

Senior

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor’s degree in Engineering, a Life Science or related field with 5+ years of relevant experience, including experience in Quality Assurance and ISO, or an equivalent combination of education and experience, preferably in a medical devices’ or regulated industry environment
Responsibilities
  • Participate in the development and qualification activities for new and existing products.
  • Lead and participate in project teams coordinating the quality efforts to design, develop, and continuously improve products. Plan, schedule, conduct, or coordinate detailed phases of the engineering work for projects with various scopes.
  • Perform work which involves conventional engineering practice but may include a variety of complex features, such as conflicting design requirements, unsuitability of standard materials, and difficult coordination requirements.
  • Perform engineering work including one or more of the following: Design and implement methods and procedures for inspecting, testing, and evaluating the precision and accuracy of equipment.
  • Develop and validate measurement methods.
  • Monitor design control to assure that new products meet guidelines, develop success measurements, and maintain currency with design control standards per regulatory and industry standards.
  • Support developmental projects in the area of quality assurance.
  • Analyze reports and returned products and recommend corrective and preventive action.
  • Perform statistical analysis and determine the responsibility for products or materials that do not meet required standards and specifications.
  • Participate in NCR or CAPA board as necessary.
  • Assist in and perform QSR training.
  • Support activities during FDA inspections, FDB inspections, and notified body audits.
  • Participate in the development of standard operating procedures.
  • Prepare documentation for inspection/testing procedures.
  • Perform responsibilities required by the Quality System and other duties as assigned.
  • Select, manage, train, and develop staff. Establish objectives and assignments and provide ongoing feedback through performance reviews and development plans.
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures.
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company.
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures.
Desired Qualifications
  • Advanced degree preferred
  • Experience in auditing, design review, sterilization, project management, and/or product development highly desired
  • Experience with Electronic devices and or PCBAs
  • Experience with Contract Manufactured Electromechanical Medical device products

Penumbra Inc. specializes in creating medical devices for treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses on a specific range of specialized devices and emphasizes continuous research and development to enhance their offerings. The company's goal is to deliver high-quality medical solutions that meet the needs of healthcare providers and improve patient outcomes.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • The neurovascular devices market is projected to grow at a CAGR of 8.1% until 2028.
  • Rising demand for minimally invasive procedures supports Penumbra's product focus.
  • Asia-Pacific's healthcare growth presents expansion opportunities for Penumbra.

What critics are saying

  • Don Kassing's retirement may create a temporary leadership gap at Penumbra.
  • Italian government's payback provision indicates potential future financial liabilities.
  • Penumbra's Costa Rica expansion could face operational challenges or delays.

What makes Penumbra Inc unique

  • Penumbra specializes in innovative devices for neurovascular and peripheral vascular conditions.
  • The company offers a broad portfolio, including the Penumbra System and Indigo System.
  • Penumbra's focus on minimally invasive procedures aligns with current medical trends.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
BioSpace
Apr 29th, 2025
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

ALAMEDA, Calif., April 29, 2025 /PRNewswire/ - Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.

Neuro News International
Apr 24th, 2025
Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements

Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements.

PR Newswire
Apr 3rd, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release And Conference Call For April 23, 2025

ALAMEDA, Calif., April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time. A press release with first quarter 2025 financial results will be issued after market close that day.Webcast & Conference Call InformationThe conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life

Penumbrainc
Mar 17th, 2025
Latest Data on Penumbra's CAVT Technology to Be Presented at SIR 2025: STRIDE, STRIKE-PE, and More

Latest data on Penumbra's CAVT technology to be presented at SIR 2025: STRIDE, STRIKE-PE, and more.

Neuro News International
Feb 28th, 2025
Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access

Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access.